Skip to main content

Harvard Apparatus Regenerative Technology, Inc.

HRGN
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001563665

In the last 90 days, Harvard Apparatus Regenerative Technology, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Key figures

Insider buysLast 90 days, $394.5K in total
1
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding HRGN, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding HRGN at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Harvard Apparatus Regenerative Technology, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 25, 2026 (view filing)10:51 AM ETSep 11-1514 daysLateHe JunliCEOPPurchase+368.6K$1.07+$394.5K+38.2%1.33M after2 lots
Dec 1, 2025 (view filing)Nov 256 daysLateHe JunliCEOPPurchase+3.00K$1.70+$5.10K+1.1%280.6K after
Oct 1, 2025 (view filing)Sep 301 dayHe JunliCEOPPurchase+300$1.98+$594+0.1%277.6K after
Sep 24, 2025 (view filing)Sep 222 daysLateHe JunliCEOPPurchase+11.2K$1.85+$20.8K+4.2%277.3K after
Sep 2, 2025 (view filing)Aug 2112 daysLateHe JunliCEOPPurchase+4.05K$1.72+$6.97K+1.5%266.1K after
Jan 2, 2025 (view filing)Dec 24, 20249 daysLateHe JunliCEOPPurchase+2.30K$2.87+$6.60K+0.9%262.0K after
Sep 12, 2024 (view filing)Aug 2716 daysLateHe JunliCEOPPurchase+5.10K$3.37+$17.2K+2.0%259.7K after
Jul 2, 2024 (view filing)Jun 2111 daysLateHe JunliCEOPPurchase+1.60K$2.80+$4.48K+0.6%254.6K after
Jan 3, 2024 (view filing)Dec 27, 20237 daysLateHe JunliCEOPPurchase+2.70K$4.76+$12.9K+1.1%253.0K after
Dec 18, 2023 (view filing)Dec 144 daysHe JunliCEOPPurchase+900$4.92+$4.43K+0.4%250.3K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Harvard Apparatus Regenerative Technology, Inc. at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding HRGN in 13F filings for Q2 2026.